The most common mutations regard the RAS gene (mainly that coding for the isoforms K-RAS), involving around 30% of all cancer types; mutations in the RAF gene are around 8% of all cancer types, whereas mutations in the MEK and ERK kinases are less frequent (1%). This evidence concerns the gene MAP2K7 and cancer.